Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2025-12-25 @ 1:05 AM
NCT ID:
NCT00906893
Eligibility Criteria:
Inclusion Criteria:
* Patients over 18
* Patients with a malignant tumour glioblastomas proposed for a radical treatment consisting in conformational radiotherapy and/or chemotherapy
* Signed informed consent
Exclusion Criteria:
* Patients who can't undergo radiotherapy or chemotherapy
* Patients with distant metastases known before inclusion except renal cancer where patients with metastases can be included
* Patients suffering of a second cancer or treated before by radiotherapy in the tumour site.
* Pregnant and breast feeding women, women in age to procreate without contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00906893
Study Brief:
Protocol Section:
NCT00906893